首页> 外文OA文献 >Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study

【2h】

Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study

机译：皮下来的皮下杀氧质单药治疗的长期安全性和有效性：武丘研究的2年开放标签延伸的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Atsushi Ogata; Koichi Amano; Hiroaki Dobashi; Masayuki Inoo; Tomonori Ishii; Tsuyoshi Kasama; Shinichi Kawai; Atsushi Kawakami; Tatsuya Koike; Hisaaki Miyahara; Toshiaki Miyamoto; Yasuhiko Munakata; Akira Murasawa; Norihiro Nishimoto; Noriyoshi Ogawa; Tomohiro Ojima; Hajime Sano; Kenrin Shi; Eisuke Shono; Eiichi Suematsu; Hiroki Takahashi; Yoshiya Tanaka; Hiroshi Tsukamoto; Akira Nomura;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study [J] . Ogata Atsushi, Amano Koichi, Dobashi Hiroaki, The Journal of rheumatology . 2015,第5期

机译：皮下Tocilizumab单药疗法的长期安全性和有效性：MUSASHI研究2年开放标签扩展的结果
2. Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: Results from the open-label extension of the SHINOBI study [J] . Atsushi Ogata, Yoshiya Tanaka, Tomonori Ishii, Modern rheumatology . 2019,第5期

机译：每周皮下对皮肤病患者的长期安全性和疗效，对类风湿性关节炎的患者进行了对皮下对皮下丁证章的反应不足：Shinobi研究的开放标签延伸结果
3. LONGTERM EFFICACY AND SAFETY OF INOTERSEN FOR HEREDITARY TRANSTHYRETIN AMYLOIDOSIS: NEURO-TTR OPEN-LABEL EXTENSION 2-YEAR UPDATE [J] . Brannagan Thomas, Cruz Marcia Waddington, Wang Annabel, Muscle and Nerve . 2019,第S1期

机译：遗传性Transtin淀粉样蛋白蛋白腺苷病的长期疗效和安全性：Neuro-TTR开放标签延长2年更新
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Extended report: Long-term safety and efficacy of tocilizumab an anti-IL-6 receptor monoclonal antibody in monotherapy in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study [O] . N Nishimoto, N Miyasaka, K Yamamoto, -1

机译：扩展报告：类风湿关节炎患者单一疗法中抗IL-6受体单克隆抗体托珠单抗的长期安全性和有效性（STREAM研究）：一项为期5年的扩展研究的安全性和有效性证据
7. Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: Results from the open-label extension of the SHINOBI study [O] . Atsushi Ogata, Yoshiya Tanaka, Tomonori Ishii, 2018

机译：每周皮下对皮肤病患者的长期安全性和功效类风湿性关节炎的患者每隔一周对皮下对皮下丁证的反应不足：Shinobi研究的开放标签延伸结果

Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study

著录项

相似文献

相关主题

期刊订阅